盈康生命
(300143)
| 流通市值：64.86亿 | | | 总市值：75.76亿 |
| 流通股本：6.42亿 | | | 总股本：7.50亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,227,709,136.74 | 823,222,466.04 | 416,230,884.39 | 1,470,797,895.06 |
| 营业收入 | 1,227,709,136.74 | 823,222,466.04 | 416,230,884.39 | 1,470,797,895.06 |
| 二、营业总成本 | 1,121,158,642.67 | 754,772,394.67 | 382,865,011.79 | 1,319,452,815.92 |
| 营业成本 | 906,559,106.89 | 604,820,945.84 | 304,853,668.78 | 1,050,533,271.16 |
| 税金及附加 | 2,720,655.51 | 1,859,382.65 | 779,771.37 | 3,731,728.78 |
| 销售费用 | 44,109,259.88 | 31,508,030.67 | 17,094,740.99 | 63,211,833.69 |
| 管理费用 | 128,320,176.19 | 91,033,669.65 | 46,917,988.88 | 148,075,759.48 |
| 研发费用 | 36,844,629.34 | 25,057,697.42 | 13,073,292.94 | 52,238,723.57 |
| 财务费用 | 2,604,814.86 | 492,668.44 | 145,548.83 | 1,661,499.24 |
| 其中:利息费用 | 8,387,688.79 | 5,670,529.72 | 3,493,293.39 | 7,579,883.69 |
| 其中:利息收入 | 7,409,215.23 | 4,929,599.67 | 3,500,498.07 | 6,490,599.43 |
| 加:公允价值变动收益 | 0 | - | - | -3,135,839.28 |
| 加:投资收益 | 720,440.44 | 666,712.56 | 28,580.82 | 1,266,414.19 |
| 净敞口套期收益 | 0 | - | - | - |
| 汇兑收益 | 0 | - | - | - |
| 资产处置收益 | 319,822.34 | 299,814.65 | 297,314.63 | 43,674.4 |
| 资产减值损失(新) | -76,677.54 | -238,353.26 | - | -4,114,778.53 |
| 信用减值损失(新) | -6,021,747.42 | -2,110,890.41 | -3,026,574.95 | -16,749,199.68 |
| 其他收益 | 12,713,557.7 | 8,685,539.18 | 4,036,382.07 | 13,354,163.06 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 114,205,889.59 | 75,752,894.09 | 34,701,575.17 | 142,009,513.3 |
| 加:营业外收入 | 1,205,726.45 | 285,181.23 | 143,384.65 | 5,412,845.96 |
| 减:营业外支出 | 4,196,947.28 | 2,909,837.57 | 672,261.94 | 15,900,646.28 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 111,214,668.76 | 73,128,237.75 | 34,172,697.88 | 131,521,712.98 |
| 减:所得税费用 | 28,014,887.72 | 18,878,286.29 | 8,115,539.45 | 32,323,211.26 |
| 六、净利润 | 83,199,781.04 | 54,249,951.46 | 26,057,158.43 | 99,198,501.72 |
| 持续经营净利润 | 83,199,781.04 | 54,249,951.46 | 26,057,158.43 | 99,198,501.72 |
| 终止经营净利润 | 0 | - | - | - |
| 归属于母公司股东的净利润 | 82,544,665.51 | 54,801,148.25 | 26,225,857.82 | 100,436,255.25 |
| 少数股东损益 | 655,115.53 | -551,196.79 | -168,699.39 | -1,237,753.53 |
| (一)基本每股收益 | 0.13 | 0.09 | 0.04 | 0.16 |
| (二)稀释每股收益 | 0.13 | 0.09 | 0.04 | 0.16 |
| 八、其他综合收益 | -64,371.68 | 13,864.67 | 10,995.46 | 109,556.83 |
| 归属于母公司股东的其他综合收益 | -64,371.68 | 13,864.67 | 10,995.46 | 109,556.83 |
| 九、综合收益总额 | 83,135,409.36 | 54,263,816.13 | 26,068,153.89 | 99,308,058.55 |
| 归属于母公司股东的综合收益总额 | 82,480,293.83 | 54,815,012.92 | 26,236,853.28 | 100,545,812.08 |
| 归属于少数股东的综合收益总额 | 655,115.53 | -551,196.79 | -168,699.39 | -1,237,753.53 |
| 公告日期 | 2024-10-28 | 2024-08-23 | 2024-04-26 | 2024-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |